Becker R H, Albus U, Kress I, Linz W, Vasmant D, Delarue F, Sraer J D
Hoechst AG, Frankfurt, F.R.G.
J Cardiovasc Pharmacol. 1989;13 Suppl 3:S31-4. doi: 10.1097/00005344-198900133-00008.
Evidence for effects of angiotensin converting enzyme (ACE) on isolated human glomeruli was provided using specific binding of tritium-labeled ramiprilat, a potent inhibitor of ACE. [3H]ramiprilat bound to isolated glomeruli, depending on time and temperature, displaying a KD of 3.8 nmol/L and a Bmax of 853 fmol/mg protein. Specific binding represented more than 90% of total binding. Dissociation occurred rapidly after dilution of the sample with incubation buffer or after addition of an excess of unlabeled inhibitor. Binding of [3H]ramiprilat was also inhibited by increasing concentrations of enalaprilat, another ACE inhibitor. ACE is a zinc-containing enzyme. Addition of EGTA to the assay, which chelates zinc ions, completely prevented binding. This was reversed by divalent Zn2+ and Ca2+ ions, but not by magnesium. Binding of [3H]ramiprilat to isolated glomeruli was maximal at pH 8, which also is optimal for ACE activity. The binding of [3H]ramiprilat to isolated human glomeruli is specific, and resembles the characteristics which have been found earlier for enzyme activity of ACE. Thus, binding of [3H]ramiprilat to isolated glomeruli can be assumed to be directed to ACE.
利用氚标记的雷米普利拉(一种有效的血管紧张素转换酶抑制剂)的特异性结合,提供了血管紧张素转换酶(ACE)对分离的人肾小球作用的证据。[3H]雷米普利拉与分离的肾小球结合,这取决于时间和温度,其解离常数(KD)为3.8 nmol/L,最大结合量(Bmax)为853 fmol/mg蛋白质。特异性结合占总结合量的90%以上。在用孵育缓冲液稀释样品或加入过量未标记的抑制剂后,解离迅速发生。[3H]雷米普利拉的结合也受到另一种血管紧张素转换酶抑制剂依那普利拉浓度增加的抑制。血管紧张素转换酶是一种含锌酶。在测定中加入螯合锌离子的乙二醇双四乙酸(EGTA)可完全阻止结合。二价锌离子和钙离子可逆转这种情况,但镁离子不能。[3H]雷米普利拉与分离的肾小球的结合在pH 8时最大,这也是血管紧张素转换酶活性的最佳pH值。[3H]雷米普利拉与分离的人肾小球的结合是特异性的,并且类似于早期发现的血管紧张素转换酶活性的特征。因此,可以认为[3H]雷米普利拉与分离的肾小球的结合是针对血管紧张素转换酶的。